Cargando…

Antiplatelet therapy does not influence outcome or host response biomarkers during sepsis: a propensity-matched analysis

Detalles Bibliográficos
Autores principales:	Wiewel, MA, De Stoppelaar, SF, Van Vught, LA, Frencken, JF, Hoogendijk, AJ, Klouwenberg, PM Klein, Horn, J, Bonten, MJ, Schultz, MJ, Zwinderman, AH, Cremer, OL, Van der Poll, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471074/ http://dx.doi.org/10.1186/cc14110

Ejemplares similares

Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis
por: Wiewel, Maryse A., et al.
Publicado: (2016)

Effect of admission hyperglycemia in sepsis patients with or without a history of diabetes
por: Vught, LA Van, et al.
Publicado: (2015)

Presence of infection in patients with presumed sepsis at the time of ICU admission
por: Klouwenberg, PMC Klein, et al.
Publicado: (2014)

A high anti-inflammatory response is associated with intermediate-term mortality in patients with sepsis
por: Frencken, JF, et al.
Publicado: (2015)

O064: Validation and assessment of the new surveillance paradigm for ventilator-associated events
por: Van Mourik, MS, et al.
Publicado: (2013)

Reduced responsiveness of blood leukocytes to lipopolysaccharide does not predict nosocomial infections in critically ill patients
por: Van Vught, LA, et al.
Publicado: (2015)

Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients
por: Hoogendijk, Arie J., et al.
Publicado: (2015)

Use of Centre for Disease Control criteria to classify infections in critically ill patients: results from an interobserver agreement study
por: Klouwenberg, PMC Klein, et al.
Publicado: (2012)

Epidemiology, management and clinical outcomes of ICU-acquired enterococcal bacteraemias
por: Ong, DSY, et al.
Publicado: (2014)

Impact of HIV infection on the presentation, outcome and host response in patients admitted to the intensive care unit with sepsis; a case control study
por: Wiewel, Maryse A., et al.
Publicado: (2016)

The host response in critically ill sepsis patients on statin therapy: a prospective observational study
por: Wiewel, Maryse A., et al.
Publicado: (2018)

Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients
por: van Vught, Lonneke A., et al.
Publicado: (2016)

Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study
por: Klein Klouwenberg, Peter M. C., et al.
Publicado: (2015)

Risk factors, host response and outcome of hypothermic sepsis
por: Wiewel, Maryse A., et al.
Publicado: (2016)

The leukocyte non-coding RNA landscape in critically ill patients with sepsis
por: Scicluna, Brendon P, et al.
Publicado: (2020)

Effectiveness of nebulized amphotericin B to eradicate Candida colonization from the lower respiratory tracts of ICU patients
por: Ong, DSY, et al.
Publicado: (2012)

Increased mortality in elderly patients with acute respiratory distress syndrome is not explained by host response
por: Schouten, Laura R. A., et al.
Publicado: (2019)

Robustness of sepsis-3 criteria in critically ill patients
por: Verboom, Diana M., et al.
Publicado: (2019)

Patients with hypothermic sepsis have a unique gene expression profile compared to patients with fever and sepsis
por: Harmon, Matthew B. A., et al.
Publicado: (2022)

The circulatory small non‐coding RNA landscape in community‐acquired pneumonia on intensive care unit admission
por: Khan, Hina N., et al.
Publicado: (2021)

The Impact of HIV Co-Infection on the Genomic Response to Sepsis
por: Huson, Michaëla A. M., et al.
Publicado: (2016)

Defining sepsis in the ICU: a sensitivity analysis
por: Klouwenberg, P Klein, et al.
Publicado: (2011)

Immune suppression is associated with enhanced systemic inflammatory, endothelial and procoagulant responses in critically ill patients
por: Brands, Xanthe, et al.
Publicado: (2022)

Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome
por: Ong, David S. Y., et al.
Publicado: (2016)

Intracellular expression of granzymes A, B, K and M in blood lymphocyte subsets of critically ill patients with or without sepsis
por: García‐Laorden, M. Isabel, et al.
Publicado: (2021)

Correction to: Predicting the clinical trajectory in critically ill patients with sepsis: a cohort study
por: Klein Klouwenberg, Peter M. C., et al.
Publicado: (2020)

Predicting the clinical trajectory in critically ill patients with sepsis: a cohort study
por: Klein Klouwenberg, Peter M. C., et al.
Publicado: (2019)

Systemic administration of E-selectin-directed dexamethasone liposomes attenuates pulmonary inflammation in a mouse model of ventilator-induced lung injury
por: Hegeman, MA, et al.
Publicado: (2009)

Ongoing Health Care Expenditure in Survivors of Sepsis in The Intensive Care Unit
por: Koster-Brouwer, M, et al.
Publicado: (2015)

Validation of a novel surveillance paradigm for ventilator-associated events
por: Klein Klouwenberg, Peter MC, et al.
Publicado: (2013)

Matrix metalloproteinase-8: a useful biomarker to refine the diagnosis of community-acquired pneumonia upon intensive care unit admission?
por: Uhel, Fabrice, et al.
Publicado: (2019)

Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study
por: van de Groep, Kirsten, et al.
Publicado: (2018)

Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: a prospective cohort study
por: Uhel, Fabrice, et al.
Publicado: (2020)

Consumptive coagulopathy is associated with a disturbed host response in patients with sepsis
por: van Vught, Lonneke A., et al.
Publicado: (2021)

The circular RNA landscape in specific peripheral blood mononuclear cells of critically ill patients with sepsis
por: Khan, Hina N., et al.
Publicado: (2020)

Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study
por: Peters-Sengers, Hessel, et al.
Publicado: (2021)

Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation
por: Reijnders, Tom D. Y., et al.
Publicado: (2022)

Increased early systemic inflammation in patients with ICU-acquired weakness
por: Witteveen, E, et al.
Publicado: (2015)

Nebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort study
por: Ong, David SY, et al.
Publicado: (2013)

A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts
por: McHugh, Leo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3c5f6e0qm1vscsis16lkevsbm2